SLC5A5 and breast cancer: Compared to untreated cells, BC cells treated with CI-994 or MS-275 show a highly significant (p < 0.001) increase of NIS transcript, whereas AR-42 and chidamide drug treatment shows either low or non-significant increase of NIS transcript, respectively (Figure 2A).